JP2022523212A5 - - Google Patents
Info
- Publication number
- JP2022523212A5 JP2022523212A5 JP2021549801A JP2021549801A JP2022523212A5 JP 2022523212 A5 JP2022523212 A5 JP 2022523212A5 JP 2021549801 A JP2021549801 A JP 2021549801A JP 2021549801 A JP2021549801 A JP 2021549801A JP 2022523212 A5 JP2022523212 A5 JP 2022523212A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962811456P | 2019-02-27 | 2019-02-27 | |
| US62/811,456 | 2019-02-27 | ||
| PCT/US2020/019724 WO2020176527A1 (en) | 2019-02-27 | 2020-02-25 | Triterpenoid antifungals for the treatment or prevention of pneumocystis spp. pneumonia |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523212A JP2022523212A (ja) | 2022-04-21 |
| JP2022523212A5 true JP2022523212A5 (https=) | 2023-02-24 |
| JPWO2020176527A5 JPWO2020176527A5 (https=) | 2023-02-24 |
| JP7581219B2 JP7581219B2 (ja) | 2024-11-12 |
Family
ID=70005768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549801A Active JP7581219B2 (ja) | 2019-02-27 | 2020-02-25 | ニューモシスチス属種（Ｐｎｅｕｍｏｃｙｓｔｉｓ ｓｐｐ．）肺炎を治療又は予防するためのトリテルペノイド系抗真菌薬 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12594266B2 (https=) |
| EP (1) | EP3930716B1 (https=) |
| JP (1) | JP7581219B2 (https=) |
| KR (1) | KR20210133241A (https=) |
| CN (1) | CN113631165A (https=) |
| AU (1) | AU2020228036B2 (https=) |
| BR (1) | BR112021016876A2 (https=) |
| CA (1) | CA3131298A1 (https=) |
| EA (1) | EA202192344A1 (https=) |
| ES (1) | ES3055272T3 (https=) |
| IL (1) | IL285839A (https=) |
| MA (1) | MA55081A (https=) |
| MX (2) | MX2021010311A (https=) |
| TW (1) | TWI910099B (https=) |
| WO (1) | WO2020176527A1 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166135A (en) * | 1988-09-12 | 1992-11-24 | Merck & Company, Inc. | Method for the control of pneumocystis carinii |
| DK173802B1 (da) * | 1988-09-12 | 2001-11-05 | Merck & Co Inc | Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner |
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| JP5245057B2 (ja) | 2006-04-03 | 2013-07-24 | メルク・シャープ・アンド・ドーム・コーポレーション | 抗真菌剤 |
| WO2010019204A1 (en) | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| CN108883152A (zh) * | 2016-01-08 | 2018-11-23 | 奇达拉治疗公司 | 防止和治疗肺孢子虫感染的方法 |
| MA49889A (fr) * | 2017-04-10 | 2020-06-24 | Scynexis Inc | Agents antifongiques utilisés en association |
| KR102807716B1 (ko) * | 2017-08-04 | 2025-05-13 | 싸이넥시스, 인크. | 산성 pH에서 증진된 활성을 갖는 항진균제 |
-
2020
- 2020-02-25 BR BR112021016876A patent/BR112021016876A2/pt unknown
- 2020-02-25 JP JP2021549801A patent/JP7581219B2/ja active Active
- 2020-02-25 AU AU2020228036A patent/AU2020228036B2/en active Active
- 2020-02-25 WO PCT/US2020/019724 patent/WO2020176527A1/en not_active Ceased
- 2020-02-25 US US17/432,926 patent/US12594266B2/en active Active
- 2020-02-25 CA CA3131298A patent/CA3131298A1/en active Pending
- 2020-02-25 KR KR1020217030157A patent/KR20210133241A/ko active Pending
- 2020-02-25 MX MX2021010311A patent/MX2021010311A/es unknown
- 2020-02-25 EA EA202192344A patent/EA202192344A1/ru unknown
- 2020-02-25 EP EP20714386.8A patent/EP3930716B1/en active Active
- 2020-02-25 ES ES20714386T patent/ES3055272T3/es active Active
- 2020-02-25 CN CN202080023125.XA patent/CN113631165A/zh active Pending
- 2020-02-25 MA MA055081A patent/MA55081A/fr unknown
- 2020-02-27 TW TW109106501A patent/TWI910099B/zh active
-
2021
- 2021-08-24 IL IL285839A patent/IL285839A/en unknown
- 2021-08-26 MX MX2025004197A patent/MX2025004197A/es unknown